Northwest Biotherapeutics, Inc. Common stock
NWBO
NWBO was delisted on the 16th of December, 2016.
9 hedge funds and large institutions have $409K invested in Northwest Biotherapeutics, Inc. Common stock in 2020 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, reducing their positions, and closing their positions.
259% more capital invested
Capital invested by funds: $114K → $409K (+$295K)
80% more funds holding
Funds holding: 5 → 9 (+4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MSAM
Moloney Securities Asset Management
Manchester,
Missouri
|
+$83.5K |
| 2 |
AIP
Almanack Investment Partners
Wayne,
Pennsylvania
|
+$34K |
| 3 |
OCG
Opus Capital Group
Cincinnati,
Ohio
|
+$29.8K |
| 4 |
GG
Gofen & Glossberg
Chicago,
Illinois
|
+$19K |
| 5 |
GWI
Grace & White Inc
Ny,
New York
|
+$16K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
MSAM
1
Moloney Securities Asset Management
Manchester,
Missouri
| $159K | +$83.5K | +54,650 | +111% |
|
|
WJWM
2
Williams Jones Wealth Management
New York
| $76K | – | – | – |
|
|
OCG
3
Opus Capital Group
Cincinnati,
Ohio
| $68K | +$29.8K | +19,500 | +78% |
|
|
AIP
4
Almanack Investment Partners
Wayne,
Pennsylvania
| $34K | +$34K | +22,500 | New |
|
|
LDB
5
Lee, Danner & Bass
Nashville,
Tennessee
| $30K | – | – | – |
|
|
GG
6
Gofen & Glossberg
Chicago,
Illinois
| $19K | +$19K | +12,740 | New |
|
|
GWI
7
Grace & White Inc
Ny,
New York
| $16K | +$16K | +10,600 | New |
|
8
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| $7K | +$274 | +190 | +4% |
|
NWBO Hedge Fund Activity: Q4 2020 in Review
9 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Northwest Biotherapeutics, Inc. Common stock (NWBO) for Q4 2020, worth a combined $409K — up 259% from $114K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new NWBO positions and 0 closed out — a net gain of 4 holders — while 3 added to existing stakes and 0 trimmed.
The largest buyer was Moloney Securities Asset Management, adding an estimated $83.5K.
- 9 institutional investors held Northwest Biotherapeutics, Inc. Common stock (NWBO) as of Q4 2020, up from 5 in Q3 2020.
- Funds reported $409K of Northwest Biotherapeutics, Inc. Common stock stock for Q4 2020, up 259% quarter-over-quarter.
- 4 funds opened new Northwest Biotherapeutics, Inc. Common stock positions in Q4 2020 and 0 closed out, a net change of +4 holders.
- The largest Northwest Biotherapeutics, Inc. Common stock buyer in Q4 2020 was Moloney Securities Asset Management, an estimated $83.5K added.
Based on aggregated 13F filings for Q4 2020.